- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Intas Pharmaceuticals names new leaders in Gene Therapy, IT, Quality Control, learning and development

Intas Pharmaceuticals has announced a series of leadership appointments across several core areas, including gene therapy, information technology, quality control, and learning and development. The company shared details of the new appointments through LinkedIn updates.
Dr T M Chozhavel Rajanathan has been appointed as Deputy General Manager – Gene Therapy. He brings over 19 years of experience spanning bio-analytical development, molecular biology, process optimization, biochemistry, biophysical characterization, and cell-based assays.
Intas expressed confidence in his ability to contribute meaningfully to its biosimilars mission, stating, "We are confident that his deep domain insights will further strengthen our efforts toward realising our mission of “Biosimilars for Billions.”
" Thrilled to bring my scientific journey to Intas, where cutting-edge analytical innovation fuels the future of gene therapy and biologics", Dr. Rajanathan said.
In the digital domain, Pravin Mahajan has joined the company as Associate Vice President – Information Technology. Mahajan has over 23 years of experience, and has led SAP-enabled digital transformations across diverse industries.
"His deep expertise in full lifecycle implementations and support for the FI/CO module on the S/4 HANA platform will play a key role in accelerating our ambitious digital journey," the Company said on Pravin appointment.
Mahajan added, "Proud to be part of Intas' digital evolution where smart technology, sharp strategy and bold thinking come together to power purposeful transformation."
Sharad Bedade has been named Deputy General Manager – Quality Control at the Company.
"Thrilled to join Intas in its pursuit of excellence, excited to drive impactful quality outcomes with innovation, precision, and purpose," Sharad said.
Additionally, the company has appointed Sushil Barkur as Associate Vice President – Learning & Development.
With over 24 years of experience in Learning & Development, Organisation Development interventions, and Talent Management, Sushil brings a wealth of knowledge and strategic insight.
The Company shared, "His expertise will be instrumental in nurturing a stronger learning culture across our Sales, R&D, Manufacturing, and Corporate teams. Sushil’s deep understanding of psychometric assessments will also play a key role in shaping impactful training programs—empowering our people to grow, lead, and innovate."
" Proud to join a company that champions learning - I'm here to spark growth, inspire potential, and build future-ready leaders at Intas," Sushil said.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751